StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2022 - 10 - 27
4
Sector
Electronic technology
1
Health technology
2
Non-energy minerals
1
Tags
Acquire
3
Acquisition
3
Agreement
7
Air
3
Alliances
5
America
6
Automotive
3
Awards
5
Biotech-bay
8
Biotech-beach
3
Brands
3
Cancer
7
Charging
3
Clinical-trials-phase-ii
5
Collaboration
4
Commercial
4
Conference
47
Contract
6
Corporation
15
Day
3
Disease
3
Earnings
10
Energy
18
Europe
5
Events
7
Expected
3
Financial
105
Global
16
Group
12
Growth
17
Health
6
Home
3
International
8
Life
3
Lithium
3
Management
4
Market
26
Media
6
Meeting
4
Mobile
3
Money
3
N/a
387
Offering
3
Partnership
5
Pharmaceutical
6
Pharmaceuticals
7
Program
5
Report
41
Research
12
Results
124
Sales
6
Software
4
Solar
5
Solutions
7
Study
4
Technology
10
Therapeutics
25
Trial
12
Update
22
Year
9
Entities
Cypress development corp
1
Ericsson
1
Harrow health, inc.
1
Neurocrine biosciences, inc.
1
Symbols
CYDVF
1
ERIC
1
HROW
1
NBIX
1
Exchanges
Nasdaq
4
Crawled Date
2024 - 01 - 04
11
2023 - 12 - 12
12
2023 - 12 - 06
13
2023 - 11 - 06
12
2023 - 10 - 31
12
2023 - 10 - 30
11
2023 - 10 - 17
12
2023 - 10 - 16
12
2023 - 09 - 28
12
2023 - 09 - 27
11
2023 - 09 - 26
16
2023 - 09 - 20
12
2023 - 09 - 18
12
2023 - 09 - 12
11
2023 - 09 - 11
13
2023 - 09 - 06
12
2023 - 07 - 17
10
2023 - 07 - 11
12
2023 - 07 - 06
11
2023 - 06 - 28
11
2023 - 06 - 27
11
2023 - 06 - 21
10
2023 - 06 - 20
11
2023 - 06 - 08
10
2023 - 06 - 05
13
2023 - 05 - 31
14
2023 - 05 - 30
10
2023 - 05 - 25
11
2023 - 05 - 23
10
2023 - 05 - 11
12
2023 - 04 - 24
10
2023 - 04 - 17
10
2023 - 02 - 22
10
2023 - 01 - 09
13
2023 - 01 - 05
11
2023 - 01 - 04
10
2022 - 12 - 19
13
2022 - 12 - 15
12
2022 - 12 - 12
10
2022 - 12 - 08
10
2022 - 11 - 30
10
2022 - 11 - 03
11
2022 - 11 - 01
15
2022 - 10 - 31
11
2022 - 10 - 26
17
2022 - 10 - 24
11
2022 - 10 - 17
13
2022 - 10 - 13
10
2022 - 10 - 11
10
2022 - 09 - 28
11
2022 - 09 - 13
10
2022 - 09 - 08
10
2022 - 09 - 06
11
2022 - 08 - 23
13
2022 - 08 - 11
10
2022 - 08 - 01
11
2022 - 07 - 19
10
2022 - 07 - 13
11
2022 - 07 - 12
12
2022 - 07 - 04
17
Crawled Time
13:00
2
14:00
2
Source
www.biospace.com
2
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Study
crawled date :
2022 - 10 - 27
save search
New Study Reveals That Consumers Want Digital Interactions With Brands to Feel More Like Personal Conversations
Published:
2022-10-27
(Crawled : 14:00)
- prnewswire.com
ERIC
|
News
|
$5.085
0.49%
14M
|
Electronic Technology
|
-11.3%
|
O:
-0.18%
H:
0.18%
C:
-2.14%
brands
study
Neurocrine Biosciences Initiates Phase 2 Clinical Study Evaluating NBI-1117568 in Adults with Schizophrenia
Published:
2022-10-27
(Crawled : 14:00)
- biospace.com/
NBIX
M
|
$130.31
-1.68%
260K
|
Health Technology
|
16.88%
|
O:
0.39%
H:
0.78%
C:
-0.52%
nbi-1117
schizophrenia
study
phase 2
CYPRESS DEVELOPMENT ENGAGES THYSSENKRUPP NUCERA FOR DESIGN AND ENGINEERING OF CHLOR-ALKALI PLANT IN FEASIBILITY STUDY
Published:
2022-10-27
(Crawled : 13:00)
- prnewswire.com
CYDVF
|
$0.4786
43K
|
Non-Energy Minerals
|
-36.58%
|
O:
-1.65%
H:
3.72%
C:
3.72%
study
Melt Pharmaceuticals Announces Dosing of Last Patient in Phase 2 Pivotal Efficacy and Safety Study for MELT-300
Published:
2022-10-27
(Crawled : 13:00)
- biospace.com/
HROW
|
$10.48
-3.41%
530K
|
Health Technology
|
-1.91%
|
O:
0.0%
H:
0.83%
C:
-0.5%
melt-300
pharmaceuticals
study
phase 2
Gainers vs Losers
70%
30%
Top 10 Gainers
AGBA
|
News
|
$1.305
226.25%
130M
|
Finance
EGOX
|
$0.0503
39.72%
320M
|
RWOD
|
$10.52
31.56%
5.9M
|
n/a
ZCMD
|
$1.905
31.38%
30M
|
Commercial Services
MRDB
4
|
$0.536
27.65%
2M
|
n/a
BSFC
|
$0.0822
27.64%
75M
|
Manufacturing
TPET
|
$0.4121
25.68%
45M
|
n/a
NVFY
|
$2.65
25.59%
33M
|
Consumer Durables
INDO
|
$5.1
25.0%
15M
|
Energy Minerals
CHRO
|
$1.53
24.9%
100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.